This company is no longer activeThe company may no longer be operating, as it may be out of business. Find out why through their latest events.See Latest EventsVersarien（VRS）株式概要バーサリエン社は、イギリス、ヨーロッパ、北米、そして国際的に、様々な産業分野にエンジニアリング・ソリューションを提供している。 詳細VRS ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性0/6配当金0/6リスク分析マイナスの株主資本 過去5年間で収益は年間3.7%減少しました。 過去1年間で株主の希薄化は大幅に進んだ 意味のある時価総額がありません ( £601K )+3 さらなるリスクすべてのリスクチェックを見るVRS Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueUK£Current PriceUK£0.000142.9% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-12m9m2016201920222025202620282031Revenue UK£381.6kEarnings UK£35.8kAdvancedSet Fair ValueView all narrativesVersarien plc 競合他社Zenova GroupSymbol: AIM:ZEDMarket cap: UK£761.5kDirecta PlusSymbol: AIM:DCTAMarket cap: UK£7.0mHardideSymbol: AIM:HDDMarket cap: UK£30.3mHarvest MineralsSymbol: AIM:HMIMarket cap: UK£1.8m価格と性能株価の高値、安値、推移の概要Versarien過去の株価現在の株価UK£0.000152週高値UK£0.0005952週安値UK£0.000042ベータ1.121ヶ月の変化0%3ヶ月変化0%1年変化-73.68%3年間の変化-99.87%5年間の変化-99.90%IPOからの変化-99.90%最新ニュースReported Earnings • Jun 30First half 2025 earnings released: EPS: UK£0 (vs UK£0.002 loss in 1H 2024)First half 2025 results: EPS: UK£0 (improved from UK£0.002 loss in 1H 2024). Revenue: UK£1.47m (down 41% from 1H 2024). Net loss: UK£1.32m (loss narrowed 21% from 1H 2024).お知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct ListingReported Earnings • Mar 27Full year 2024 earnings released: UK£0.003 loss per share (vs UK£0.055 loss in FY 2023)Full year 2024 results: UK£0.003 loss per share (improved from UK£0.055 loss in FY 2023). Revenue: UK£2.42m (down 56% from FY 2023). Net loss: UK£3.99m (loss narrowed 71% from FY 2023).お知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdomお知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct ListingNew Risk • Dec 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (UK£1.15m market cap, or US$1.45m). Minor Risk Latest financial reports are more than 6 months old (reported March 2024 fiscal period end).最新情報をもっと見るRecent updatesReported Earnings • Jun 30First half 2025 earnings released: EPS: UK£0 (vs UK£0.002 loss in 1H 2024)First half 2025 results: EPS: UK£0 (improved from UK£0.002 loss in 1H 2024). Revenue: UK£1.47m (down 41% from 1H 2024). Net loss: UK£1.32m (loss narrowed 21% from 1H 2024).お知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct ListingReported Earnings • Mar 27Full year 2024 earnings released: UK£0.003 loss per share (vs UK£0.055 loss in FY 2023)Full year 2024 results: UK£0.003 loss per share (improved from UK£0.055 loss in FY 2023). Revenue: UK£2.42m (down 56% from FY 2023). Net loss: UK£3.99m (loss narrowed 71% from FY 2023).お知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdomお知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct ListingNew Risk • Dec 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (UK£1.15m market cap, or US$1.45m). Minor Risk Latest financial reports are more than 6 months old (reported March 2024 fiscal period end).お知らせ • Dec 10Versarien plc Announces the Launch of New BiosensorsVersarien Plc announced the launch of a new biosensor chip utilising novel graphene barristor sensor platform technology. These graphene barristor devices, developed in South Korea by A Barristor Company ("ABC"), will utilise chemical vapour deposition ("CVD") grown graphene, that is produced under a Versarien licence. Versarien has signed a distribution agreement with ABC to distribute the products in the UK and Europe. A barristor (triode device) is a new type of graphene-based transistor with a Schottky barrier between graphene and silicon. The current modulation is amplified more than 10,000 times compared to graphene field-effect transistors ("GFET") enabling the barristor transistors to overcome many GFET limitations. In these new products, the graphene surface is terminated with either pyrenebutanoic acid succinimidyl ester ("PBASE") or a customer preferred linker. PBASE is one of the most frequently used linkers for the surface modification of field-effect transistor (FET) biosensors based on carbon nanotubes and graphene. The products can be supplied as individual chips or on a wafer scale. It is expected that the CVD graphene used in the products will be supplied by MCK Tech Co. Ltd. ("MCK Tech") in South Korea, which is an existing Licensing partner of Versarien, and it will also undertake some of the device fabrication. The range of sensor products to be distributed by Versarien may be expanded at a later date based on ABC's product developments, such as in infrared detection, gas/chemical detection, temperature detection or multiple sensor on a chip technology.お知らせ • Sep 30Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million.Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million on September 30, 2024. The consideration of £0.55 million is payable in cash, in 16 equal quarterly instalments of £0.0034 million, commencing three months from completion. Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable. In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £0.146 million and had net assets at 30 September 2023 of £0.411 million. The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses. The proceeds of the disposal will be used for the Company's general corporate and working capital purposes. Matthew Johnson, Adam Cowl of SP Angel Corporate Finance LLP acted as financial advisor for Versarien plc.お知らせ • Jul 25Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 846,153,845 Price\Range: £0.00065 Transaction Features: Subsequent Direct ListingNew Risk • Jun 07New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.9m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (460% increase in shares outstanding). Market cap is less than US$10m (UK£1.21m market cap, or US$1.54m).お知らせ • Mar 29Versarien plc, Annual General Meeting, Apr 30, 2024Versarien plc, Annual General Meeting, Apr 30, 2024, at 09:30 Coordinated Universal Time. Location: Riverbank House, 2 Swan Lane London United KingdomReported Earnings • Mar 28Full year 2023 earnings released: UK£0.055 loss per share (vs UK£0.027 loss in FY 2022)Full year 2023 results: UK£0.055 loss per share (further deteriorated from UK£0.027 loss in FY 2022). Revenue: UK£5.45m (down 26% from FY 2022). Net loss: UK£13.5m (loss widened 156% from FY 2022).お知らせ • Mar 21Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 492,000,000 Price\Range: £0.00125 Transaction Features: Subsequent Direct Listingお知らせ • Jan 19Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: £0.0008 Transaction Features: Subsequent Direct ListingNew Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (156% increase in shares outstanding). Market cap is less than US$10m (UK£1.10m market cap, or US$1.40m). Minor Risk Latest financial reports are more than 6 months old (reported March 2023 fiscal period end).お知らせ • Nov 09Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 165,389,817 Price\Range: £0.00275 Transaction Features: Subsequent Direct Listingお知らせ • Jul 21+ 1 more updateVersarien plc Announces Resignation of Neill Ricketts from the BoardVersarien plc received confirmation that Neill Ricketts has resigned from the Board with effect from 14 July 2023 and is no longer a Director of the Company. He continues on garden leave with no day-to-day responsibilities unless required by the company.New Risk • Jul 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 70% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£4.9m free cash flow). Share price has been highly volatile over the past 3 months (40% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (70% increase in shares outstanding). Market cap is less than US$10m (UK£4.40m market cap, or US$5.76m).Reported Earnings • Jun 11First half 2023 earnings released: UK£0.015 loss per share (vs UK£0.011 loss in 1H 2022)First half 2023 results: UK£0.015 loss per share (further deteriorated from UK£0.011 loss in 1H 2022). Revenue: UK£2.62m (down 33% from 1H 2022). Net loss: UK£3.20m (loss widened 55% from 1H 2022).お知らせ • May 19Versarien plc Provides an Update on the Trials of Versarien's Water-Based Graphene Admixture, CementeneTM in Precast Concrete Mixs That Have Been Carried Out by Banagher Precast Concrete LimitedVersarien plc provided an update on the trials of Versarien's water-based graphene admixture, CementeneTM in precast concrete mixes that have been carried out by Banagher Precast Concrete Limited ("Banagher"), a precast concrete manufacturer and supplier of precast concrete products to the civil engineering and construction industries throughout the UK and Ireland. The Company reported that preliminary results from the work undertaken by Banagher have demonstrated that 20% of ordinary Portland cement ("OPC") can be removed from Banagher's typical precast concrete mix when CementeneTM is added, whilst maintaining the compression strength of the concrete. These initial results demonstrate the significant potential to reduce CO2 emissions without impacting the performance of the concrete. The production of 1 kg of CementeneTM is estimated to generate approximately 1.44 kg of CO2 emissions and approximately 5 kg of Cementene TM is used per cubic metre of concrete. The production of 1 km of OPC emits approximately 0.8 kg of CO2 and c.500 kg of OPC is used per cubic metre of Banagher's precast concrete. Therefore, the removal of 20% of OPC in the precast concrete mix (approximately 100 kg) equates to a net saving of approximately 72.8 kg of CO2 emissions per cubic metre of concrete poured. Based on Banagher's average 60,000 cubic metre output of concrete per year, the savings achieved in these trials mean that the incorporation of CementeneTM could offer almost 4.4 million kg of CO2 savings per year at a cost the Company believes is competitive for this level of emissions reduction.Reported Earnings • Feb 25Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: UK£0.028 loss per share (improved from UK£0.035 loss in FY 2021). Revenue: UK£7.40m (down 3.6% from FY 2021). Net loss: UK£5.29m (loss narrowed 19% from FY 2021). Revenue missed analyst estimates by 24%. Earnings per share (EPS) exceeded analyst estimates by 56%. Revenue is forecast to stay flat during the next 3 years compared to a 1.7% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.分析記事 • Aug 05Would Versarien (LON:VRS) Be Better Off With Less Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Reported Earnings • May 13Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: UK£0.026 loss per share (up from UK£0.045 loss in FY 2021). Revenue: UK£7.63m (up 16% from FY 2021). Net loss: UK£4.94m (loss narrowed 37% from FY 2021). Revenue missed analyst estimates by 100%. Earnings per share (EPS) exceeded analyst estimates by 100%. Over the next year, revenue is expected to shrink by 21% compared to a 18% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.Price Target Changed • Apr 27Price target increased to UK£0.35Up from UK£0.26, the current price target is provided by 1 analyst. New target price is 139% above last closing price of UK£0.15. Stock is down 60% over the past year. The company is forecast to post a net loss per share of UK£0.06 next year compared to a net loss per share of UK£0.045 last year.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.分析記事 • Dec 30Would Versarien (LON:VRS) Be Better Off With Less Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Reported Earnings • Dec 08First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: UK£0.015 loss per share (up from UK£0.024 loss in 1H 2021). Revenue: UK£3.82m (up 41% from 1H 2021). Net loss: UK£2.87m (loss narrowed 31% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 39% per year whereas the company’s share price has fallen by 41% per year.分析記事 • Sep 16Shareholders May Be Wary Of Increasing Versarien plc's (LON:VRS) CEO Compensation PackageVersarien plc ( LON:VRS ) has not performed well recently and CEO Neill Ricketts will probably need to up their game...Reported Earnings • Aug 06Full year 2021 earnings released: UK£0.044 loss per share (vs UK£0.027 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: UK£6.57m (down 21% from FY 2020). Net loss: UK£7.78m (loss widened 88% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings.分析記事 • Feb 24What Kind Of Investors Own Most Of Versarien plc (LON:VRS)?Every investor in Versarien plc ( LON:VRS ) should be aware of the most powerful shareholder groups. Generally...分析記事 • Jan 27Have Insiders Been Selling Versarien plc (LON:VRS) Shares?We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...Recent Insider Transactions • Jan 23CEO & Executive Director recently sold UK£890k worth of stockOn the 21st of January, Neill Ricketts sold around 2m shares on-market at roughly UK£0.54 per share. This was the largest sale by an insider in the last 3 months. This was Neill's only on-market trade for the last 12 months.Reported Earnings • Jan 23First half 2021 earnings released: UK£0.025 loss per shareThe company reported a poor first half result with increased losses and weaker revenues and control over expenses. First half 2021 results: Revenue: UK£3.12m (down 29% from 1H 2020). Net loss: UK£4.16m (loss widened 121% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.Is New 90 Day High Low • Dec 30New 90-day high: UK£0.41The company is up 5.0% from its price of UK£0.39 on 01 October 2020. The British market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.分析記事 • Dec 15What Does Versarien's (LON:VRS) CEO Pay Reveal?The CEO of Versarien plc ( LON:VRS ) is Neill Ricketts, and this article examines the executive's compensation against...Is New 90 Day High Low • Oct 14New 90-day low: UK£0.34The company is down 12% from its price of UK£0.38 on 16 July 2020. The British market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.Reported Earnings • Sep 25Full year earnings released - UK£0.027 loss per shareOver the last 12 months the company has reported total losses of UK£4.15m, with losses widening by 67% from the prior year. Total revenue was UK£8.28m over the last 12 months, down 9.4% from the prior year.Is New 90 Day High Low • Sep 25New 90-day low: UK£0.35The company is down 19% from its price of UK£0.43 on 26 June 2020. The British market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.株主還元VRSGB ChemicalsGB 市場7D0%0.09%-0.1%1Y-73.7%10.2%18.0%株主還元を見る業界別リターン: VRS過去 1 年間で10.2 % の収益を上げたUK Chemicals業界を下回りました。リターン対市場: VRSは、過去 1 年間で18 % のリターンを上げたUK市場を下回りました。価格変動Is VRS's price volatile compared to industry and market?VRS volatilityVRS Average Weekly Movementn/aChemicals Industry Average Movement7.9%Market Average Movement5.7%10% most volatile stocks in GB Market11.9%10% least volatile stocks in GB Market3.1%安定した株価: VRSの株価は、 UK市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間のVRSのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト201064Steve Hodgewww.versarien.comバーサリエン社は、イギリス、ヨーロッパ、北米、そして国際的に様々な産業分野にエンジニアリング・ソリューションを提供している。同社はテクノロジー事業と成熟事業の2つのセグメントで事業を展開している。数層グラフェン「Nanene」、グラフェン強化ポリマー「Polygrene」、数層六方晶窒化ホウ素ナノプレートレット粉末「Hexotene」、エネルギー貯蔵デバイス用グラフェン系ナノ材料のほか、「Graphinks」の名称で、さまざまな印刷プロセス、基板、用途向けの導電性グラフェンインクを提供している。同社は、グラフェン強化プラスチック製品（グラフェン強化モバイルアクセサリー、射出成形製品、工具箱、輸送用トレイ、PU発泡タンク、真空成形製品など）を提供している。また、特殊インサートやブランク、カッティングナイフ、耐摩耗部品、流量制御用ノズルやバルブインサート、防衛・航空宇宙用タングステンカーバイド部品からなる焼結タングステンカーバイド製品も提供している。バーサリエン社は2010年に設立され、英国ロングホープに本社を置いている。もっと見るVersarien plc 基礎のまとめVersarien の収益と売上を時価総額と比較するとどうか。VRS 基礎統計学時価総額UK£601.00k収益（TTM）-UK£3.65m売上高(TTM)UK£1.39m0.4xP/Sレシオ-0.2xPER（株価収益率VRS は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計VRS 損益計算書（TTM）収益UK£1.39m売上原価UK£890.00k売上総利益UK£503.00kその他の費用UK£4.15m収益-UK£3.65m直近の収益報告Mar 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.00061グロス・マージン36.11%純利益率-262.02%有利子負債／自己資本比率-273.6%VRS の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/01/30 05:59終値2025/11/28 00:00収益2025/03/31年間収益2024/09/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Versarien plc 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Lydia KennyBerenberg
Reported Earnings • Jun 30First half 2025 earnings released: EPS: UK£0 (vs UK£0.002 loss in 1H 2024)First half 2025 results: EPS: UK£0 (improved from UK£0.002 loss in 1H 2024). Revenue: UK£1.47m (down 41% from 1H 2024). Net loss: UK£1.32m (loss narrowed 21% from 1H 2024).
お知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct Listing
Reported Earnings • Mar 27Full year 2024 earnings released: UK£0.003 loss per share (vs UK£0.055 loss in FY 2023)Full year 2024 results: UK£0.003 loss per share (improved from UK£0.055 loss in FY 2023). Revenue: UK£2.42m (down 56% from FY 2023). Net loss: UK£3.99m (loss narrowed 71% from FY 2023).
お知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdom
お知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct Listing
New Risk • Dec 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (UK£1.15m market cap, or US$1.45m). Minor Risk Latest financial reports are more than 6 months old (reported March 2024 fiscal period end).
Reported Earnings • Jun 30First half 2025 earnings released: EPS: UK£0 (vs UK£0.002 loss in 1H 2024)First half 2025 results: EPS: UK£0 (improved from UK£0.002 loss in 1H 2024). Revenue: UK£1.47m (down 41% from 1H 2024). Net loss: UK£1.32m (loss narrowed 21% from 1H 2024).
お知らせ • May 14Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.425 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,545,454,545 Price\Range: £0.000275 Transaction Features: Subsequent Direct Listing
Reported Earnings • Mar 27Full year 2024 earnings released: UK£0.003 loss per share (vs UK£0.055 loss in FY 2023)Full year 2024 results: UK£0.003 loss per share (improved from UK£0.055 loss in FY 2023). Revenue: UK£2.42m (down 56% from FY 2023). Net loss: UK£3.99m (loss narrowed 71% from FY 2023).
お知らせ • Mar 27Versarien plc, Annual General Meeting, Apr 28, 2025Versarien plc, Annual General Meeting, Apr 28, 2025. Location: the offices of fieldfisher llp, riverbank house, 2 swan lane, ec4r 3tt, london United Kingdom
お知らせ • Jan 29Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.246038 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 745,569,784 Price\Range: £0.00033 Transaction Features: Subsequent Direct Listing
New Risk • Dec 23New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (over 6x increase in shares outstanding). Market cap is less than US$10m (UK£1.15m market cap, or US$1.45m). Minor Risk Latest financial reports are more than 6 months old (reported March 2024 fiscal period end).
お知らせ • Dec 10Versarien plc Announces the Launch of New BiosensorsVersarien Plc announced the launch of a new biosensor chip utilising novel graphene barristor sensor platform technology. These graphene barristor devices, developed in South Korea by A Barristor Company ("ABC"), will utilise chemical vapour deposition ("CVD") grown graphene, that is produced under a Versarien licence. Versarien has signed a distribution agreement with ABC to distribute the products in the UK and Europe. A barristor (triode device) is a new type of graphene-based transistor with a Schottky barrier between graphene and silicon. The current modulation is amplified more than 10,000 times compared to graphene field-effect transistors ("GFET") enabling the barristor transistors to overcome many GFET limitations. In these new products, the graphene surface is terminated with either pyrenebutanoic acid succinimidyl ester ("PBASE") or a customer preferred linker. PBASE is one of the most frequently used linkers for the surface modification of field-effect transistor (FET) biosensors based on carbon nanotubes and graphene. The products can be supplied as individual chips or on a wafer scale. It is expected that the CVD graphene used in the products will be supplied by MCK Tech Co. Ltd. ("MCK Tech") in South Korea, which is an existing Licensing partner of Versarien, and it will also undertake some of the device fabrication. The range of sensor products to be distributed by Versarien may be expanded at a later date based on ABC's product developments, such as in infrared detection, gas/chemical detection, temperature detection or multiple sensor on a chip technology.
お知らせ • Sep 30Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million.Harper Bennett Limited completed a binding agreement to acquire AAC Cyroma Limited from Versarien plc (AIM:VRS) for £0.55 million on September 30, 2024. The consideration of £0.55 million is payable in cash, in 16 equal quarterly instalments of £0.0034 million, commencing three months from completion. Versarien will retain a charge over the assets of AAC Cyroma and Harper Bennett Limited to cover any outstanding consideration payable. In the financial year ended 30 September 2023 AAC Cyroma incurred a loss of £0.146 million and had net assets at 30 September 2023 of £0.411 million. The disposal of AAC Cyroma is in line with the Company's strategy to focus on its core graphene technology and divesting of its mature businesses. The proceeds of the disposal will be used for the Company's general corporate and working capital purposes. Matthew Johnson, Adam Cowl of SP Angel Corporate Finance LLP acted as financial advisor for Versarien plc.
お知らせ • Jul 25Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.55 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 846,153,845 Price\Range: £0.00065 Transaction Features: Subsequent Direct Listing
New Risk • Jun 07New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -UK£1.9m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£1.9m free cash flow). Share price has been highly volatile over the past 3 months (15% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (460% increase in shares outstanding). Market cap is less than US$10m (UK£1.21m market cap, or US$1.54m).
お知らせ • Mar 29Versarien plc, Annual General Meeting, Apr 30, 2024Versarien plc, Annual General Meeting, Apr 30, 2024, at 09:30 Coordinated Universal Time. Location: Riverbank House, 2 Swan Lane London United Kingdom
Reported Earnings • Mar 28Full year 2023 earnings released: UK£0.055 loss per share (vs UK£0.027 loss in FY 2022)Full year 2023 results: UK£0.055 loss per share (further deteriorated from UK£0.027 loss in FY 2022). Revenue: UK£5.45m (down 26% from FY 2022). Net loss: UK£13.5m (loss widened 156% from FY 2022).
お知らせ • Mar 21Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.615 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 492,000,000 Price\Range: £0.00125 Transaction Features: Subsequent Direct Listing
お知らせ • Jan 19Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.4 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 500,000,000 Price\Range: £0.0008 Transaction Features: Subsequent Direct Listing
New Risk • Dec 26New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (24% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (156% increase in shares outstanding). Market cap is less than US$10m (UK£1.10m market cap, or US$1.40m). Minor Risk Latest financial reports are more than 6 months old (reported March 2023 fiscal period end).
お知らせ • Nov 09Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million.Versarien plc has completed a Follow-on Equity Offering in the amount of £0.454822 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 165,389,817 Price\Range: £0.00275 Transaction Features: Subsequent Direct Listing
お知らせ • Jul 21+ 1 more updateVersarien plc Announces Resignation of Neill Ricketts from the BoardVersarien plc received confirmation that Neill Ricketts has resigned from the Board with effect from 14 July 2023 and is no longer a Director of the Company. He continues on garden leave with no day-to-day responsibilities unless required by the company.
New Risk • Jul 16New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 70% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-UK£4.9m free cash flow). Share price has been highly volatile over the past 3 months (40% average weekly change). Earnings have declined by 24% per year over the past 5 years. Shareholders have been substantially diluted in the past year (70% increase in shares outstanding). Market cap is less than US$10m (UK£4.40m market cap, or US$5.76m).
Reported Earnings • Jun 11First half 2023 earnings released: UK£0.015 loss per share (vs UK£0.011 loss in 1H 2022)First half 2023 results: UK£0.015 loss per share (further deteriorated from UK£0.011 loss in 1H 2022). Revenue: UK£2.62m (down 33% from 1H 2022). Net loss: UK£3.20m (loss widened 55% from 1H 2022).
お知らせ • May 19Versarien plc Provides an Update on the Trials of Versarien's Water-Based Graphene Admixture, CementeneTM in Precast Concrete Mixs That Have Been Carried Out by Banagher Precast Concrete LimitedVersarien plc provided an update on the trials of Versarien's water-based graphene admixture, CementeneTM in precast concrete mixes that have been carried out by Banagher Precast Concrete Limited ("Banagher"), a precast concrete manufacturer and supplier of precast concrete products to the civil engineering and construction industries throughout the UK and Ireland. The Company reported that preliminary results from the work undertaken by Banagher have demonstrated that 20% of ordinary Portland cement ("OPC") can be removed from Banagher's typical precast concrete mix when CementeneTM is added, whilst maintaining the compression strength of the concrete. These initial results demonstrate the significant potential to reduce CO2 emissions without impacting the performance of the concrete. The production of 1 kg of CementeneTM is estimated to generate approximately 1.44 kg of CO2 emissions and approximately 5 kg of Cementene TM is used per cubic metre of concrete. The production of 1 km of OPC emits approximately 0.8 kg of CO2 and c.500 kg of OPC is used per cubic metre of Banagher's precast concrete. Therefore, the removal of 20% of OPC in the precast concrete mix (approximately 100 kg) equates to a net saving of approximately 72.8 kg of CO2 emissions per cubic metre of concrete poured. Based on Banagher's average 60,000 cubic metre output of concrete per year, the savings achieved in these trials mean that the incorporation of CementeneTM could offer almost 4.4 million kg of CO2 savings per year at a cost the Company believes is competitive for this level of emissions reduction.
Reported Earnings • Feb 25Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: UK£0.028 loss per share (improved from UK£0.035 loss in FY 2021). Revenue: UK£7.40m (down 3.6% from FY 2021). Net loss: UK£5.29m (loss narrowed 19% from FY 2021). Revenue missed analyst estimates by 24%. Earnings per share (EPS) exceeded analyst estimates by 56%. Revenue is forecast to stay flat during the next 3 years compared to a 1.7% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
分析記事 • Aug 05Would Versarien (LON:VRS) Be Better Off With Less Debt?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Reported Earnings • May 13Full year 2022 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2022 results: UK£0.026 loss per share (up from UK£0.045 loss in FY 2021). Revenue: UK£7.63m (up 16% from FY 2021). Net loss: UK£4.94m (loss narrowed 37% from FY 2021). Revenue missed analyst estimates by 100%. Earnings per share (EPS) exceeded analyst estimates by 100%. Over the next year, revenue is expected to shrink by 21% compared to a 18% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has fallen by 17% per year but the company’s share price has fallen by 48% per year, which means it is performing significantly worse than earnings.
Price Target Changed • Apr 27Price target increased to UK£0.35Up from UK£0.26, the current price target is provided by 1 analyst. New target price is 139% above last closing price of UK£0.15. Stock is down 60% over the past year. The company is forecast to post a net loss per share of UK£0.06 next year compared to a net loss per share of UK£0.045 last year.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Non-Executive Chairman Savory Hill was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
分析記事 • Dec 30Would Versarien (LON:VRS) Be Better Off With Less Debt?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Reported Earnings • Dec 08First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: UK£0.015 loss per share (up from UK£0.024 loss in 1H 2021). Revenue: UK£3.82m (up 41% from 1H 2021). Net loss: UK£2.87m (loss narrowed 31% from 1H 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 39% per year whereas the company’s share price has fallen by 41% per year.
分析記事 • Sep 16Shareholders May Be Wary Of Increasing Versarien plc's (LON:VRS) CEO Compensation PackageVersarien plc ( LON:VRS ) has not performed well recently and CEO Neill Ricketts will probably need to up their game...
Reported Earnings • Aug 06Full year 2021 earnings released: UK£0.044 loss per share (vs UK£0.027 loss in FY 2020)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: UK£6.57m (down 21% from FY 2020). Net loss: UK£7.78m (loss widened 88% from FY 2020). Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has only fallen by 34% per year, which means it has not declined as severely as earnings.
分析記事 • Feb 24What Kind Of Investors Own Most Of Versarien plc (LON:VRS)?Every investor in Versarien plc ( LON:VRS ) should be aware of the most powerful shareholder groups. Generally...
分析記事 • Jan 27Have Insiders Been Selling Versarien plc (LON:VRS) Shares?We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be...
Recent Insider Transactions • Jan 23CEO & Executive Director recently sold UK£890k worth of stockOn the 21st of January, Neill Ricketts sold around 2m shares on-market at roughly UK£0.54 per share. This was the largest sale by an insider in the last 3 months. This was Neill's only on-market trade for the last 12 months.
Reported Earnings • Jan 23First half 2021 earnings released: UK£0.025 loss per shareThe company reported a poor first half result with increased losses and weaker revenues and control over expenses. First half 2021 results: Revenue: UK£3.12m (down 29% from 1H 2020). Net loss: UK£4.16m (loss widened 121% from 1H 2020). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 21% per year, which means it has not declined as severely as earnings.
Is New 90 Day High Low • Dec 30New 90-day high: UK£0.41The company is up 5.0% from its price of UK£0.39 on 01 October 2020. The British market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
分析記事 • Dec 15What Does Versarien's (LON:VRS) CEO Pay Reveal?The CEO of Versarien plc ( LON:VRS ) is Neill Ricketts, and this article examines the executive's compensation against...
Is New 90 Day High Low • Oct 14New 90-day low: UK£0.34The company is down 12% from its price of UK£0.38 on 16 July 2020. The British market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
Reported Earnings • Sep 25Full year earnings released - UK£0.027 loss per shareOver the last 12 months the company has reported total losses of UK£4.15m, with losses widening by 67% from the prior year. Total revenue was UK£8.28m over the last 12 months, down 9.4% from the prior year.
Is New 90 Day High Low • Sep 25New 90-day low: UK£0.35The company is down 19% from its price of UK£0.43 on 26 June 2020. The British market is down 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 13% over the same period.
